Tel: +44 (0) 161 721 2202
Fax: +44 (0) 161 721 2005
Reaxa offers licensing of 2-MBT technology for solid phase synthesis and production of peptides. This active ester coupling of amino acid residues avoids the safety issues associated with the widely-used HOBt technique and in addition offers a number of significant advantages for the peptide industry. The reagent has been proved to give a safer and more cost effect process and is a non-explosive replacement for coupling additives HOBt, HOAt and Cl-HOBt.
Further Information: http://www.reaxa.com